Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Volume: 373, Issue: 3, Pages: 232 - 242
Published: Jul 15, 2015
Abstract
Background null Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. null Methods null In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at...
Paper Details
Title
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Published Date
Jul 15, 2015
Volume
373
Issue
3
Pages
232 - 242
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.